Title of Study: Beckman Navios Flow Cytometric analysis for COVID 19 (SARS-CoV-2) Study
You are being asked to participate in a research study. No research activity is to be conducted until you have had an opportunity to review this consent form, ask any questions you may have, and sign this document. The purpose of this research study is to gather novel data regarding the immune response from patients known to be infected by SARS-CoV 2 virus and compare with unaffected individuals to better understand the mechanisms of viral response and to aid in the development of targeted therapy. Flow cytometric analysis is intended for in vitro diagnostic use in the identification of normal/abnormal blood cell populations. A given amount of peripheral blood sample (2 tubes, collected in K2EDTA and Heparin) drawn for the subject/patient continuation of care (including, but not limited to blood chemistries, white blood count) will be used for the flow cytometry instrument validation study. When the study sample is collected, it will be given a code number. No identifying information such as your name or birth date will be directly linked to your research sample. Although the results of this study may be published, no information that could identify you will be included. There is no compensation for participation in the validation study. Your participation in this study is complete once the blood has been collected. There are minimal risks, side effects or discomfort associated with peripheral blood draw (bleeding, rash, bruising, pain).